… The Michael J. Fox Foundation for Parkinson's Research is pleased to announce the establishment of its first grant program for Parkinson's disease research. Effective immediately, the Foundation is … anticipated announcement date of awards in late February or early March 2001. It is anticipated that up to 10 proposals …

… brains. Today, we are in a similar position in Parkinson’s research. There are 13 therapies specifically targeting … disease, the protein alpha-synuclein accumulates into clumps and impairs the ability of brain cells to … and multiple system atrophy (MSA). More tracers mean better diagnosis and therapies for people with Parkinson’s and …

… publication. They discussed progress in Parkinson’s disease research and the Foundation’s de-risking model. The … time and again to be one of the most challenging areas of research for the drug industry ... But new breakthroughs in … high risks with our investment to start projects at very early stages. The goal is then to develop data packages to …

… MJFF is expediting Parkinson’s disease research, working tirelessly to advance global opportunities … MJFF is committed to supporting efforts that de-risk early-stage Parkinson's disease research to accelerate … and speed the translation of promising biology into and across therapeutic pipelines. To see our exciting …

… supported projects are driving toward new treatments and early diagnosis for people with Parkinson’s disease (PD). Here we … Scientists believe this inflammation leads to cell loss. Researchers at Neuropore Therapies are testing the drug …

… known but critical part of The Michael J. Fox Foundation's research is our tools program.  Its goal is to provide the most needed research tools for Parkinson's, so scientists can focus on … their important work. Scientists must often make their own research tools, such as cell lines, antibodies and viral …